论文信息 - Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia - 字舞流文

Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia

O. Casasnovas | P. Feugier | S. Leprêtre | S. Chevret | R. Letestu | M. Béné | A. Delmer | V. Leblond | B. Cazin | O. Tournilhac | B. Mahé | F. Nguyen‐Khac | H. Maisonneuve | B. Royer | B. Corront | F. Cymbalista | T. Aurran | D. Roos-Weil | R. Delépine | Sandrine Vaudaux | E. Van Den Neste